Our team’s reading recommendation for this month goes to “Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance”[1] by Shi-Yan Ren et al., an extremely

Our team’s reading recommendation for this month goes to “Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase

Our team’s reading recommendation for this month goes to “Unravelling the collateral damage of antibiotics on gut bacteria”[1] by Maier et al., a very interesting paper

Our team’s reading recommendation for this month goes to “Update on human genetic susceptibility to COVID-19: susceptibility to virus and response”[1] by Colona et al., an

Our team’s reading recommendation for this month goes to “The promise of the gut microbiome as part of individualized treatment strategies”[1] by Schupack et al., a

Our team’s reading recommendation for this month goes to “Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of

Our team’s reading recommendation for this month goes to “Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet,

Our team’s reading recommendation for this month goes to “Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19” by Yun Kit

Our team’s reading recommendation for this month goes to “Comprehensive Genomic Characterization of Fifteen Early-Onset Lynch-Like Syndrome Colorectal Cancers”[i] by Mariano Golubicki et al. from the Molecular